Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin.
Tobin
A M
AM
Kirby
B
B
D017255:Acitretin / Q000627:therapeutic use*; D000169:Acrodermatitis / Q000188:drug therapy*; D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006225:Hand; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use*; D008875:Middle Aged; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007641:Keratolytic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab; D017255:Acitretin